Medulloblastoma Treatment using Gene Therapy

Journal Title: Journal of Gene Therapy - Year 2013, Vol 1, Issue 1

Abstract

Usually initiated in cerebellum and the fourth ventricle and caused by the secondary increased intracranial pressure due to blockage of the fourth ventricle, medulloblastoma (MB) is the most common malignant brain tumor in children. Traditionally, surgical therapy is predominantly conducted with maximal resection of the tumor and followed by radiation or chemotherapy according to its philological subtypes. However, due to the fact that the traditional treatments result in unsatisfactory peripheral prognosis and the final death from relapse to most of the patients, increasing efforts have been made in the field of gene therapy to improve the prognosis. So far, four of gene therapy strategies have been tested in cells or animal xenograft models including 1) oncolytic virotherapy using adenovirus, reovirus, myxoma virus, and measles virus; 2) suicide gene therapy, focusing on HSV-tk with GCV system and rCE with CPT-11 system; 3) radiation sensitivity enhancement by down regulation of MMP-9, uPAR, SPARC, CDK6 or elevation of NIS; and 4) miRNA-based gene therapy. To date, gene therapy to MB has been proven to be promising at the level of cells lines and xenograft mouse models although no clinical trials have been conducted. In this paper, we review the relevant gene therapy strategies for the MB treatments and discuss the pertinent challenges, further refinement and future directions in this field.

Authors and Affiliations

Yujing Li

Keywords

Related Articles

A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors

Background: Recognition sequences for microRNAs (miRs) that are down-regulated in tumor cells have recently been used to render lytic viruses tumor-specific. Since different tumor types downregulate different miRs, this...

cis-Antisense RNA and Transcriptional Interference: Coupled Layers of Gene Regulation

Antisense transcription is omnipresent occurring broadly in most living organisms. Growing evidence suggests the presence of noncoding cis-antisense RNA’s that can silence gene expression. Recent studies also indicate th...

MicroRNA-124 Suppresses Tumor Cell Proliferation and Invasion by Targeting CD164 Signaling Pathway in Non-Small Cell Lung Cancer

MicroRNAs play critical roles in regulating gene expression andvarious cellular processes in human cancer malignant progression. Down-regulated expression of miR-124 gene has been shown to be significantly associated wit...

Enhanced Incretin Effects of Exendin-4 Expressing Chimeric Plasmid Based On Two-Step Transcription Amplification System with Dendritic Bioreducible Polymer for the Treatment of Type 2 Diabetes

Glucagon-like peptide 1 (GLP-1) agonist, exenxdin-4, is currently being advanced as a promising diabetes remedy via a variety of incretin actions similar with GLP-1. In this study, we investigated an effective anti-diabe...

Molecular Physiology of G-CIMP+ Glioblastomas: Therapeutic Implications

A fundamental premise of gene therapy as it pertains to oncology is precision medicine, whereby therapeutic intervention is matched to unique vulnerabilities dictated molecular physiology of the cancer [1]. Cancers pre...

Download PDF file
  • EP ID EP246284
  • DOI 10.13188/2381-3326.1000001
  • Views 111
  • Downloads 0

How To Cite

Yujing Li (2013). Medulloblastoma Treatment using Gene Therapy. Journal of Gene Therapy, 1(1), 1-6. https://europub.co.uk/articles/-A-246284